Add Yahoo as a preferred source to see more of our stories on Google. With holiday parties in full gear, it's that time of year that will eventually lead to people getting sick. Feeling ill after that ...

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...

Immunization with the long-acting monoclonal antibody nirsevimab may provide stronger protection against hospitalizations for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Every fall and winter, a familiar set of illnesses makes ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related RSV ...

Six recent studies conclude that maternal respiratory syncytial virus (RSV) vaccination and the long-acting monoclonal ...

Doctors say the number of vaccinated mothers remains too low to show a measurable dip in infant hospitalisations.

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants. The US Food and Drug Administration ...

A "high" level of respiratory illness activity in Mississippi could be causing people such as children and older adults to seek medical care, health officials say. The CDC complied this data by using ...

Breakthrough mRNA technologies, strong U.S. leadership, and rising awareness of RSV risks fuel unprecedented market expansion.Austin, United States, April 27, 2026 (GLOBE NEWSWIRE) -- According to SNS ...

Respiratory syncytial virus, or RSV, is a common virus that infects the nose, throat and lungs, according to the U.S. Centers for Disease Control and Prevention. Is it RSV, COVID or the flu? RSV ...